Although the antifibrotic effects of CBP/β-catenin inhibitors on lung fibrosis, liver fibrosis, and cancers have been examined6,9,11,18,19, their antifibrotic effect in endometriosis have not been investigated. This evidence concerns the gene CREBBP and endometriosis.